As of Jun 02
| -0.03 / -2.52%|
The 2 analysts offering 12-month price forecasts for Aligos Therapeutics Inc have a median target of 4.50, with a high estimate of 7.00 and a low estimate of 2.00. The median estimate represents a +287.93% increase from the last price of 1.16.
The current consensus among 2 polled investment analysts is to Buy stock in Aligos Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.